Hims & Hers officer plans sale of 29,277 shares

Officer Okupe Oluyemi has filed a Rule 144 notice to sell 29,277 Hims & Hers Class A shares previously acquired via options and restricted stock vesting.

Rhea-AI Filing Summary

Hims & Hers Health, Inc. (HIMS) is the issuer referenced in a notice under Rule 144 for a proposed sale of 29,277 shares of Class A common stock for the account of officer Okupe Oluyemi. The filing lists an aggregate market value of $876,846.15 for these shares and notes 224,935,790 Class A shares outstanding as of September 22, 2026.

The shares to be sold were acquired through a stock option exercise of 14,000 shares and multiple restricted stock vestings between March 15, 2025 and August 15, 2026. The document also reports a prior sale of 12,313 Class A shares for $354,860.66 on June 17, 2026 under Rule 144 aggregation requirements.

Key Figures

Shares to be sold under Rule 144: 29,277 shares Aggregate market value of planned sale: $876,846.15 Class A shares outstanding: 224,935,790 shares +4 more

7 metrics

Shares to be sold under Rule 144 29,277 shares Planned sale of Hims & Hers Class A stock for officer Okupe Oluyemi

Aggregate market value of planned sale $876,846.15 Estimated value of 29,277 Class A shares to be sold

Class A shares outstanding 224,935,790 shares Total Hims & Hers Class A shares outstanding as of September 22, 2026

Recent shares sold in past 3 months 12,313 shares Class A shares sold on June 17, 2026 by Oluyemi Okupe

Proceeds from recent sale $354,860.66 Value of 12,313 Class A shares sold on June 17, 2026

Stock option exercise 14,000 shares Class A shares acquired via stock option exercise on September 22, 2026

Restricted stock vesting total 15,277 shares Class A shares from vestings on March 15, 2025; May 20, 2025; June 15, 2025; September 15, 2025; August 15, 2026

Key Terms

Rule 144, Stock Option Exercise, Restricted Stock Vesting, attorney-in-fact

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Stock Option Exercise financial

"Class A | 09/22/2026 | Stock Option Exercise | Issuer"

A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.

Restricted Stock Vesting financial

"Class A | 03/15/2025 | Restricted Stock Vesting | Issuer"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

attorney-in-fact regulatory

"as attorney-in-fact for Oluyemi Okupe."

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing mean for HIMS?

The Form 144 relates to a planned sale of 29,277 Hims & Hers Class A shares by officer Okupe Oluyemi under Rule 144. It is a regulatory notice of an intended sale of restricted or control securities, not an action by the company itself.

How many HIMS shares are planned to be sold under this Rule 144 notice?

The notice covers 29,277 shares of Hims & Hers Class A common stock. The filing lists an aggregate market value of $876,846.15 for these shares as of the planned sale date of September 22, 2026.

How were the HIMS shares in this Form 144 acquired by Okupe Oluyemi?

The filing states the shares were acquired through a stock option exercise of 14,000 shares on September 22, 2026 and restricted stock vesting events on March 15, 2025; May 20, 2025; June 15, 2025; September 15, 2025; and August 15, 2026, totaling 29,277 shares.

How many HIMS shares were sold by this person in the last three months?

The document reports that 12,313 Class A shares were sold on June 17, 2026 for $354,860.66. This disclosure is required because Rule 144 aggregates certain sales over a three-month period.

What is the total number of HIMS Class A shares outstanding mentioned in the filing?

The notice states that there were 224,935,790 Class A shares outstanding as of September 22, 2026. This figure is provided as a reference for the company’s total Class A share count at that date.

Who is executing the planned sale of HIMS shares under this Form 144?

The securities are held at Fidelity Brokerage Services LLC, and the Form 144 is signed by /s/ Jessica Spraker as a duly authorized representative of Fidelity Brokerage Services LLC, acting as attorney-in-fact for Oluyemi Okupe.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/22/2026 - 12:13 PM Accepted by SEC EDGAR 09/22/2026 - 12:12 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001907056
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Hims & Hers Health, Inc.
SEC File Number	001-38986
Address of Issuer	2269 CHESTNUT ST #523 SAN FRANCISCO CALIFORNIA 94123
Phone	415-851-0195
Name of Person for Whose Account the Securities are To Be Sold	Okupe Oluyemi
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	29277	876846.15	224935790	09/22/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A	09/22/2026	Stock Option Exercise	Issuer			14000	09/22/2026	Cash
Class A	03/15/2025	Restricted Stock Vesting	Issuer			2530	03/15/2025	Compensation
Class A	05/20/2025	Restricted Stock Vesting	Issuer			1056	05/20/2025	Compensation
Class A	06/15/2025	Restricted Stock Vesting	Issuer			311	06/15/2025	Compensation
Class A	09/15/2025	Restricted Stock Vesting	Issuer			6103	09/15/2025	Compensation
Class A	08/15/2026	Restricted Stock Vesting	Issuer			5277	08/15/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Oluyemi Okupe 2269 Chestnut Street #523 San Francisco CA 94123	Class A	09/17/2026	12313	354860.66

144: Remarks and Signature

Remarks
Date of Notice	09/22/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	05/20/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Jessica Spraker, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Oluyemi Okupe.
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)